Trading Signals: ABBV Stock Price Prediction and Forecast (Mon. Mar. 17, 2014 - Fri. Dec. 22, 2023)(AbbVie Inc.)
| ABBV latest price $85.6600 (0.53%) ($83.9000 - $85.6800) on Mon. Nov. 11, 2019. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.4% (three month average) | RSI | 78 | Latest Price | $85.6600(0.53%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ABBV advances 0.6% a day on average for past five trading days. | Weekly Trend | ABBV advances 3.8% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support ABBV advance at 0% a week (0% probability) XLV(63%) DIA(52%) SPLV(52%) VYM(52%) IVE(51%) | Factors Impacting ABBV price | ABBV will decline at least -0.7% in a week (0% probabilities). VIXM(-36%) VXX(-15%) TLT(-15%) IGOV(-4%) UUP(-0%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.7% (StdDev 1.4%) | Hourly BBV | 0 () | Intraday Trend | 0.8% | | | |
|
5 Day Moving Average | $83.36(2.76%) | 10 Day Moving Average | $82.05(4.4%) | 20 Day Moving Average | $79.43(7.84%) | To recent high | 0% | To recent low | 36% | Market Cap | $151.128b | | | | AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as as well as Parkinson's disease; metabolic diseases, comprising thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL. |